0078-0709 : Tabrecta 150 mg Oral Tablet, Film Coated
NDC: | 0078-0709 |
Labeler: | Novartis Pharmaceuticals Corporation |
Product Type: | Human Prescription Drug |
Drug Name: | Tabrecta |
Dosage Form: | Oral Tablet, Film Coated |
Application #: | NDA213591 |
Rev. Date: |
Appearance:
Markings: | DU;NVR |
Shapes: |
Oval |
Colors: |
Orange |
Size (mm): | 18 |
Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. |
NDC Package Codes:
- 0078-0709-56: 56 TABLET, FILM COATED IN 1 BOTTLE (0078‑0709‑56)
- 0078-0709-94: 56 TABLET, FILM COATED IN 1 BOTTLE (0078‑0709‑94)
Active Ingredients:
- Capmatinib
Dosage Strength:
- 150 mg
Inactive Ingredients:
- Silicon Dioxide
- Crospovidone
- Magnesium Stearate
- Mannitol
- Cellulose, Microcrystalline
- Povidone
- Sodium Lauryl Sulfate
- Ferric Oxide Red
- Ferric Oxide Yellow
- Ferrosoferric Oxide
- Hypromelloses
- Polyethylene Glycol 400
- Talc
- Titanium Dioxide /
Pharmaceutical Classes:
- Kinase Inhibitor [EPC]
- Mesenchymal Epithelial Transition Inhibitors [MoA]
- Cytochrome P450 1A2 Inhibitors [MoA]
- P-Glycoprotein Inhibitors [MoA]
- Breast Cancer Resistance Protein Inhibitors [MoA]
- Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]
- Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 0078-0716 Tabrecta 200 mg Oral Tablet, Film Coated by Novartis Pharmaceuticals Corporation
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 0078-0708Next: 0078-0713 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.